Caricamento...
Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
Alzheimer’s disease (AD) is a form of dementia and the most common progressive neurodegenerative disease (ND). The targeting of amyloid-beta (Aβ) aggregation is one of the most widely used strategies to manage AD, and efforts are being made globally to develop peptide-based compounds for the early d...
Salvato in:
| Pubblicato in: | Front Aging Neurosci |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808296/ https://ncbi.nlm.nih.gov/pubmed/29467644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00021 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|